Sapphire Therapeutics
Trademark details
Sapphire Therapeutics® is a registered trademark used for Full Line of Pharmaceutical and Biopharmaceutical Preparations Technical Consultation, Research, and Development For Others In the Fields of Biotechnology, Genomics, Proteomics, Drug Discovery, Pharmaceutical, Biopharmaceutical and Medicinal Chemistry and owned by Sapphire Therapeutics, Inc.. Full trade mark registration details, registered images and more information below.
| Goods and/or Services: | Full Line of Pharmaceutical and Biopharmaceutical Preparations Technical Consultation, Research, and Development For Others In the Fields of Biotechnology, Genomics, Proteomics, Drug Discovery, Pharmaceutical, Biopharmaceutical and Medicinal Chemistry Research and Development of New Products For Others Scientific Research Medical Research Pharmaceutical and Biopharmaceutical Research Research In the Field of Medicinal Chemistry Technology Transfer Services, Namely, Licensing of Intellectual Property |
| Serial Number: | 78665702 |
| Filing Date: | Jul 7, 2005 |
|
Last Applicant(s)/ Owner(s) of Record | Sapphire Therapeutics, Inc.1031 Us Highway 22, Suite 303 |
| Related Products: | Pharmaceuticals, Miscellaneous Services; Scientific and technological services, and research and design relating thereto; Industrial analysis and research services; Design and development of computer hardware and software; Legal services |
News and Blogs

Total : 2 View more »
News: Helsinn Picks Up Sapphire Therapeutics to Establish U.S. Subsidiary.
...EST Helsinn Picks Up Sapphire Therapeutics to Establish U.S. Subsidiary... Helsinn has bought Sapphire Therapeutics, giving this...operation. “The acquisition of Sapphire Therapeutics will also allow...
News: Sapphire Licenses a Novo Nordisk Program Related to Obesity Therapeutics.
... Sapphire Licenses a Novo Nordisk Program Related to Obesity Therapeutics GEN News Highlights Sapphire Therapeutics licensed a discovery-stage ghrelin antagonist program from Novo Nordisk. These candidates are being researched...
